GUEST
Cynthia, Caregiver
PROGRAM OVERVIEW
The DETECT Initiative Podcast-TeleECHO program provides community clinicians with valuable information about the diagnosis and management of mild cognitive impairment and Alzheimer’s disease (AD) through a series of podcast discussions between experts in the field. In addition, listeners will hear directly from a caregiver about living with someone with AD, and how healthcare practitioners can make a difference. The programs are designed to enhance clinician knowledge and improve their confidence in treating this population.
TARGET AUDIENCE
This activity is designed to meet the educational needs of U.S.-based community healthcare providers who care for patients with AD, including primary care clinicians, neurologists, geriatricians, nurses, nurse practitioners, physician assistants, geriatric psychologists, psychiatrists, pharmacists, and managed care professionals.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Evaluate the burden of Alzheimer’s disease (AD), including the process of prolonged decline in cognitive function
- Provide an accurate and timely diagnosis of AD to allow for early disease management and/or referral to specialists
- Use cognitive assessments, biomarkers and imaging to distinguish between normal aging and cognitive impairment
- Select and use the best therapeutic options for patients with AD based on up-to-date clinical data on established and emerging disease modifying therapies
- Employ best practices for multidisciplinary care coordination, workflows, and best practices for referral of patients
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
| Cynthia, Caregiver | Reports no relevant relationships with a commercial entity or manufacturer. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Debra Gordon, Medical Director for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Jessica McMullen, MPH, Program Manager for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this activity. To receive CME credit participants must:
- Read the CME information and faculty disclosures
- Complete the pre-test before listening
- Participate in the activity by listening to the podcast
- Complete the online post-test and evaluation
You will receive your certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
PROGRAM CHAIR
 | Liana Apostolova, MD, MSc, FAAN Indiana University Distinguished Professor Barbara and Peer Baekgaard Professor of Alzheimer’s Disease Research Professor in Neurology, Radiology, Medical and Molecular Genetics Indiana University School of Medicine Department of Neurology Indianapolis, IN |
FACULTY PRESENTER
 | Geoffrey C. Wall, PharmD, FCCP, BCPS John R. Ellis Distinguished Chair of Pharmacy Practice Professor of Clinical Sciences Director, Drake Drug Information Center Drake University College of Pharmacy and Health Sciences Internal Medicine Clinical Pharmacist Iowa Methodist Medical Center Des Moines, IA |
PROGRAM OVERVIEW
The DETECT podcast program provides community clinicians with valuable information about the diagnosis and management of mild cognitive impairment and Alzheimer’s disease (AD) through a series of discussions between experts in the field. In this podcast, listen to leading experts in Alzheimer’s disease discuss the potential role of medications in dementia and the use of medications in people with dementia.
TARGET AUDIENCE
This activity is designed to meet the educational needs of U.S.-based community healthcare providers who care for patients with AD, including primary care clinicians, neurologists, geriatricians, nurses, nurse practitioners, physician assistants, geriatric psychologists, psychiatrists, pharmacists, and managed care professionals.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Select and use the best therapeutic options for patients with AD based on up-to-date clinical data on established and emerging disease modifying therapies.
- Employ best practices for multidisciplinary care coordination, workflows, and best practices for referral of patients
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
| Faculty Member | Disclosures |
| Liana Apostolova, MD | Consulting Fees: Biogen, IQVIA, National Institutes of Health, Lilly, Eisai, GE HealthCare, Roche Diagnostics, Genentech, Corium, and Siemens Contracted for Research: Avid Radiopharmaceuticals, Life Molecular Imaging, and Roche Ownership Interest: Cassava Sciences |
| Geoffrey C. Wall, PharmD | Nothing to disclose |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Debra Gordon, Medical Director for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Jessica McMullen, MPH, Program Manager for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this activity. To receive CME credit participants must:
- Read the CME information and faculty disclosures
- Complete the pre-test before listening
- Participate in the activity by listening to the podcast
- Complete online post-test and evaluation
You will receive your certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
PROGRAM CHAIR
|
Liana Apostolova, MD, MSc, FAAN Indiana University Distinguished Professor Barbara and Peer Baekgaard Professor of Alzheimer’s Disease Research Professor in Neurology, Radiology, Medical and Molecular Genetics Indiana University School of Medicine Department of Neurology Indianapolis, IN |
FACULTY PRESENTER
 |
Brad Dickerson, MD, MMSc, FAAN Director, Frontotemporal Disorders Unit Massachusetts General Hospital Professor of Neurology, Harvard Medical School Boston, MA |
PROGRAM OVERVIEW
The DETECT Podcast program provides community clinicians with valuable information about the diagnosis and management of mild cognitive impairment and Alzheimer’s disease through discussions between experts in the field. In this podcast, listeners will hear two of the leading experts in Alzheimer’s disease discuss a real-life case and the challenges the patient’s condition presents.
TARGET AUDIENCE
This activity is designed to meet the educational needs of U.S.-based community healthcare providers who care for patients with AD, including primary care clinicians, neurologists, geriatricians, nurses, nurse practitioners, physician assistants, geriatric psychologists, psychiatrists, pharmacists, and managed care professionals.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Use cognitive assessments, biomarkers and imaging to distinguish between normal aging and cognitive impairment
- Select and use the best therapeutic options for patients with AD based on up-to-date clinical data on established and emerging disease modifying therapies.
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
| Faculty Member | Disclosures |
| Liana Apostolova, MD | Consulting Fees: Biogen, IQVIA, National Institutes of Health, Lilly, Eisai, GE HealthCare, Roche Diagnostics, Genentech, Corium, and Siemens Contracted for Research: Avid Radiopharmaceuticals, Life Molecular Imaging, and Roche |
| Brad Dickerson, MD | Consulting Fees: Acadia, Alector, Arkuda Therapeutics, Biogen, Denali, Eisai, Genentech, Lilly, Merck, Takeda, and Wave Life Sciences. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Debra Gordon, Medical Director for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Jessica McMullen, MPH, Program Manager for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this activity. To receive CME credit participants must:
- Read the CME information and faculty disclosures
- Complete the pre-test before listening
- Participate in the activity by listening to the podcast
- Complete online post-test and evaluation
You will receive your certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
| GUESTS |
| Olivia Matongo, MPH Vice President of Programs Alzheimer’s Association |
| Terrianne Reynolds, MPH Health Systems Director, Region 9 Alzheimer’s Association |
PROGRAM OVERVIEW
The DETECT Podcast program provides community clinicians with valuable information about the diagnosis and management of mild cognitive impairment and Alzheimer’s disease through a series of discussions between experts in the field. In this podcast, clinicians will learn about resources from the Alzheimer’s Association for their patients and caregivers.
TARGET AUDIENCE
This activity is designed to meet the educational needs of U.S.-based community healthcare providers who care for patients with AD, including primary care clinicians, neurologists, geriatricians, nurses, nurse practitioners, physician assistants, geriatric psychologists, psychiatrists, pharmacists, and managed care professionals.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Evaluate the burden of Alzheimer’s disease (AD), including the process of prolonged decline in cognitive function
- Provide an accurate and timely diagnosis of AD to allow for early disease management and/or referral to specialists.
- Employ best practices for multidisciplinary care coordination, workflows, and best practices for referral of patients
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Debra Gordon, Medical Director for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Jessica McMullen, MPH, Program Manager for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating in this activity.
- Read the information and disclosures
- Participate in the activity by listening to the podcast
- Complete online evaluation
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
PROGRAM CHAIR
 | Liana Apostolova, MD, MSc, FAAN Indiana University Distinguished Professor Barbara and Peer Baekgaard Professor of Alzheimer’s Disease Research Professor in Neurology, Radiology, Medical and Molecular Genetics Indiana University School of Medicine Department of Neurology Indianapolis, IN |
FACULTY PRESENTER
 | Diana R. Kerwin, MD, CPI President, Kerwin Medical Center Chief, Geriatric Medicine, Texas Health Presbyterian Hospital Dallas, TX |
PROGRAM OVERVIEW
This DETECT Podcast program provides primary care clinicians with valuable information about the diagnosis and management of mild cognitive impairment and Alzheimer’s disease through a discussion between experts in the field. In this podcast, listeners will hear two of the leading experts in Alzheimer’s disease discuss a real-life case and the challenges the patient’s condition presents.
TARGET AUDIENCE
This activity is designed to meet the educational needs of U.S.-based community healthcare providers who care for patients with AD, including primary care clinicians, neurologists, geriatricians, nurses, nurse practitioners, physician assistants, geriatric psychologists, psychiatrists, pharmacists, and managed care professionals
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Provide an accurate and timely diagnosis of AD to allow for early disease management and/or referral to specialists
- Employ best practices for multidisciplinary care coordination, workflows, and best practices for referral of patients
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
| Faculty Member | Disclosures |
| Liana Apostolova, MD | Consulting Fees: Biogen, IQVIA, National Institutes of Health, Lilly, Eisai, GE HealthCare, Roche Diagnostics, Genentech, Corium, and Siemens Contracted for Research: Avid Radiopharmaceuticals, Life Molecular Imaging, and Roche Ownership Interest: Cassava Sciences |
| Diana R. Kerwin, MD, CPI | Consulting Fees: Biogen, Eisai, and Roche/Genentech Contracted for Research: AbbVie, Acumen, Beren Therapeutics, Biogen, Eisai, Global Alzheimer’s Network, Lilly, and Roche/Genentech. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with commercial interests related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Debra Gordon, Medical Director for Med Learning Group has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Jessica McMullen, MPH, Program Manager for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this activity. To receive CME credit participants must:
- Read the CME information and faculty disclosures.
- Complete the pre-test before listening.
- Participate in the activity by listening to the podcast.
- Complete online post-test and evaluation.
You will receive your certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
This activity is provided by Med Learning Group.
